著者: EweK, EckardtV, KanzlerG

原題: Treatment of ulcerative colitis with olsalazine and sulphasalazine: efficacy and side-effects.

著者: HanauerS B

原題: Review article: high-dose aminosalicylates to induce and maintain remissions in ulcerative colitis.

著者: SandbornWilliam J

原題: Treatment of ulcerative colitis with oral mesalamine: advances in drug formulation, efficacy expectations and dose response, compliance, and chemoprevention.

著者: KlotzU

原題: Colonic targeting of aminosalicylates for the treatment of ulcerative colitis.

著者: KlotzUlrich, SchwabMatthias

原題: Topical delivery of therapeutic agents in the treatment of inflammatory bowel disease.

著者: MantzarisGerassimos J, SfakianakisMichael, ArchavlisEmmanuel, PetrakiKalliopi, ChristidouAngeliki, KaragiannidisAlexandros, TriadaphyllouGeorge

原題: A prospective randomized observer-blind 2-year trial of azathioprine monotherapy versus azathioprine and olsalazine for the maintenance of remission of steroid-dependent ulcerative colitis.

著者: ChourasiaM K, JainS K

原題: Pharmaceutical approaches to colon targeted drug delivery systems.

著者: BirketvedtG S, BergK J, FausaO, FlorholmenJ

原題: Glomerular and tubular renal functions after long-term medication of sulphasalazine, olsalazine, and mesalazine in patients with ulcerative colitis.

著者: RatnaikeR N, JonesT E

原題: Mechanisms of drug-induced diarrhoea in the elderly.

著者: BotomanV A, BonnerG F, BotomanD A

原題: Management of inflammatory bowel disease.

著者: EweK, BeckerK, UeberschaerB

原題: Systemic uptake of 5-aminosalicylic acid from olsalazine and eudragit L coated mesalazine in patients with ulcerative colitis in remission.

著者: NilssonA, DanielssonA, LöfbergR, BennoP, BergmanL, FausaO, FlorholmenJ, KarvonenA L, KildeboS, KollbergB

原題: Olsalazine versus sulphasalazine for relapse prevention in ulcerative colitis: a multicenter study.

著者: WrightJ P, O'KeefeE A, CumingL, JaskiewiczK

原題: Olsalazine in maintenance of clinical remission in patients with ulcerative colitis.

著者: FerryG D, KirschnerB S, GrandR J, IssenmanR M, GriffithsA M, VanderhoofJ A, FiedorekS C, WinterH S, HassallE G, WatkinsJ B

原題: Olsalazine versus sulfasalazine in mild to moderate childhood ulcerative colitis: results of the Pediatric Gastroenterology Collaborative Research Group Clinical Trial.

著者: ScheurlenC, AllgayerH, KruisW, ErdmannE, SauerbruchT

原題: Effect of olsalazine and mesalazine on human ileal and colonic (Na+ + K+)-ATPase. A possible diarrhogenic factor?

著者: WrightJ P, JewellD P, ModiglianiR, MalchowH,

原題: A randomized, double-blind, placebo-controlled trial of olsalazine for active Crohn's disease.

著者: ToliaV

原題: Sulfasalazine desensitization in children and adolescents with chronic inflammatory bowel disease.

著者: CourtneyM G, NunesD P, BerginC F, O'DriscollM, TrimbleV, KeelingP W, WeirD G

原題: Randomised comparison of olsalazine and mesalazine in prevention of relapses in ulcerative colitis.

著者: GiafferM H, O'BrienC J, HoldsworthC D

原題: Clinical tolerance to three 5-aminosalicylic acid releasing preparations in patients with inflammatory bowel disease intolerant or allergic to sulphasalazine.

著者: ZinbergJ, MolinasS, DasK M

原題: Double-blind placebo-controlled study of olsalazine in the treatment of ulcerative colitis.

著者: RambaudJ C

原題: [New treatments of hemorrhagic rectocolitis].

著者: CampbellD E, BerglindhT

原題: Pharmacology of olsalazine.

著者: WilloughbyC P, CowanR E, GouldS R, MachellR J, StewartJ B

原題: Double-blind comparison of olsalazine and sulphasalazine in active ulcerative colitis.

著者: IrelandA, JewellD P

原題: Olsalazine in patients intolerant of sulphasalazine.

著者: Sandberg-GertzénH, JärnerotG, KraazW

原題: Azodisal sodium in the treatment of ulcerative colitis. A study of tolerance and relapse-prevention properties.

著者: LevinsonR A

原題: Disodium azodisalicylate. American College of Gastroenterology Committee on FDA-Related Matters.